Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1 (Q63370740)

From Wikidata
Jump to navigation Jump to search
scientific article published on 17 December 2020
edit
Language Label Description Also known as
English
Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1
scientific article published on 17 December 2020

    Statements

    Metformin Promotes Antitumor Immunity via Endoplasmic-Reticulum-Associated Degradation of PD-L1 (English)
    0 references
    0 references
    August 2018
    0 references
    71
    0 references
    4
    0 references
    606-620.e7
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit